BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//The Closing Print//Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:The Closing Print
BEGIN:VEVENT
SUMMARY:Amgen Q3 2026 earnings\, tracked by TCP
DTSTART;VALUE=DATE:20261103
DTEND;VALUE=DATE:20261104
DTSTAMP:20261029T142128Z
UID:amgn-q3-2026-earnings@theclosingprint.net
DESCRIPTION:Amgen Q3 2026 earnings conference call Nov 3.\nSource: https:/
 /investors.amgen.com/news-and-events/events-calendar/\nCoverage: https://w
 ww.theclosingprint.net/2026/10/eli-lilly-q3-2026-earnings-retatrutide/\n\n
 More analysis at The Closing Print: https://www.theclosingprint.net
TRANSP:TRANSPARENT
URL:https://www.theclosingprint.net/2026/10/eli-lilly-q3-2026-earnings-ret
 atrutide/
X-ALT-DESC;FMTTYPE=text/html:<html><body>Amgen Q3 2026 earnings conference
  call Nov 3.<br>Source: https://investors.amgen.com/news-and-events/events
 -calendar/<br>Coverage: https://www.theclosingprint.net/2026/10/eli-lilly-
 q3-2026-earnings-retatrutide/<br><br>More analysis at The Closing Print: <
 a href="https://www.theclosingprint.net">https://www.theclosingprint.net</
 a></body></html>
BEGIN:VALARM
ACTION:DISPLAY
DESCRIPTION:Amgen Q3 2026 earnings
TRIGGER:-P1D
END:VALARM
END:VEVENT
BEGIN:VEVENT
SUMMARY:Novo Nordisk 9M 2026 results (1:30 AM ET) | TCP
DTSTART:20261104T063000Z
DTEND:20261104T073000Z
DTSTAMP:20261029T142128Z
UID:nvo-9m-2026-results@theclosingprint.net
DESCRIPTION:Novo Nordisk first nine months of 2026 results\, 7:30 AM CET.
 \nSource: https://www.novonordisk.com/investors/financial-results.html\nCo
 verage: https://www.theclosingprint.net/2026/10/eli-lilly-q3-2026-earnings
 -retatrutide/\n\nMore analysis at The Closing Print: https://www.theclosin
 gprint.net
URL:https://www.theclosingprint.net/2026/10/eli-lilly-q3-2026-earnings-ret
 atrutide/
X-ALT-DESC;FMTTYPE=text/html:<html><body>Novo Nordisk first nine months of
  2026 results, 7:30 AM CET.<br>Source: https://www.novonordisk.com/investo
 rs/financial-results.html<br>Coverage: https://www.theclosingprint.net/202
 6/10/eli-lilly-q3-2026-earnings-retatrutide/<br><br>More analysis at The C
 losing Print: <a href="https://www.theclosingprint.net">https://www.theclo
 singprint.net</a></body></html>
BEGIN:VALARM
ACTION:DISPLAY
DESCRIPTION:Novo Nordisk 9M 2026 results (1:30 AM ET)
TRIGGER:-P1D
END:VALARM
END:VEVENT
BEGIN:VEVENT
SUMMARY:TCP: US October CPI (8:30 AM ET)
DTSTART:20261110T133000Z
DTEND:20261110T140000Z
DTSTAMP:20261029T142128Z
UID:2026-11-10-us-cpi-october@theclosingprint.net
DESCRIPTION:BLS consumer price index for October.\nCoverage: https://www.t
 heclosingprint.net/2026/10/eli-lilly-q3-2026-earnings-retatrutide/\n\nMore
  analysis at The Closing Print: https://www.theclosingprint.net
URL:https://www.theclosingprint.net/2026/10/eli-lilly-q3-2026-earnings-ret
 atrutide/
X-ALT-DESC;FMTTYPE=text/html:<html><body>BLS consumer price index for Octo
 ber.<br>Coverage: https://www.theclosingprint.net/2026/10/eli-lilly-q3-202
 6-earnings-retatrutide/<br><br>More analysis at The Closing Print: <a href
 ="https://www.theclosingprint.net">https://www.theclosingprint.net</a></bo
 dy></html>
BEGIN:VALARM
ACTION:DISPLAY
DESCRIPTION:US October CPI (8:30 AM ET)
TRIGGER:-P1D
END:VALARM
END:VEVENT
BEGIN:VEVENT
SUMMARY:TCP: Medicare publishes 2028 negotiated drug prices (deadline)
DTSTART;VALUE=DATE:20261130
DTEND;VALUE=DATE:20261201
DTSTAMP:20261029T142128Z
UID:bio1023-2026-11-30-cms-2028-prices@theclosingprint.net
DESCRIPTION:Deadline for CMS to publish negotiated prices for the third cy
 cle of Medicare drug price negotiation\, effective Jan 1\, 2028.\nCoverage
 : https://www.theclosingprint.net/2026/10/eli-lilly-q3-2026-earnings-retat
 rutide/\n\nMore analysis at The Closing Print: https://www.theclosingprint
 .net
TRANSP:TRANSPARENT
URL:https://www.theclosingprint.net/2026/10/eli-lilly-q3-2026-earnings-ret
 atrutide/
X-ALT-DESC;FMTTYPE=text/html:<html><body>Deadline for CMS to publish negot
 iated prices for the third cycle of Medicare drug price negotiation, effec
 tive Jan 1, 2028.<br>Coverage: https://www.theclosingprint.net/2026/10/eli
 -lilly-q3-2026-earnings-retatrutide/<br><br>More analysis at The Closing P
 rint: <a href="https://www.theclosingprint.net">https://www.theclosingprin
 t.net</a></body></html>
BEGIN:VALARM
ACTION:DISPLAY
DESCRIPTION:Medicare publishes 2028 negotiated drug prices (deadline)
TRIGGER:-P1D
END:VALARM
END:VEVENT
BEGIN:VEVENT
SUMMARY:TCP: Eli Lilly Q4 2026 results (estimated)
DTSTART;VALUE=DATE:20270204
DTEND;VALUE=DATE:20270205
DTSTAMP:20261029T142128Z
UID:lly-q4-2026-earnings@theclosingprint.net
DESCRIPTION:Eli Lilly fourth-quarter 2026 results and first 2027 guidance
 \, before the open. Date not yet confirmed by the company.\nDate/time is a
 n estimate and may change.\nCoverage: https://www.theclosingprint.net/2026
 /10/eli-lilly-q3-2026-earnings-retatrutide/\n\nMore analysis at The Closin
 g Print: https://www.theclosingprint.net
TRANSP:TRANSPARENT
URL:https://www.theclosingprint.net/2026/10/eli-lilly-q3-2026-earnings-ret
 atrutide/
X-ALT-DESC;FMTTYPE=text/html:<html><body>Eli Lilly fourth-quarter 2026 res
 ults and first 2027 guidance, before the open. Date not yet confirmed by t
 he company.<br>Date/time is an estimate and may change.<br>Coverage: https
 ://www.theclosingprint.net/2026/10/eli-lilly-q3-2026-earnings-retatrutide/
 <br><br>More analysis at The Closing Print: <a href="https://www.theclosin
 gprint.net">https://www.theclosingprint.net</a></body></html>
BEGIN:VALARM
ACTION:DISPLAY
DESCRIPTION:Eli Lilly Q4 2026 results (estimated)
TRIGGER:-P1D
END:VALARM
END:VEVENT
END:VCALENDAR